2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stro...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-08-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427617300984 |
| _version_ | 1811295164837134336 |
|---|---|
| author | Chern-En Chiang, MD, PhD Ken Okumura, MD, PhD Shu Zhang, MD Tze-Fan Chao, MD, PhD Chung-Wah Siu, MD Toon Wei Lim, MD Anil Saxena, MD Yoshihide Takahashi, MD Wee Siong Teo, MD |
| author_facet | Chern-En Chiang, MD, PhD Ken Okumura, MD, PhD Shu Zhang, MD Tze-Fan Chao, MD, PhD Chung-Wah Siu, MD Toon Wei Lim, MD Anil Saxena, MD Yoshihide Takahashi, MD Wee Siong Teo, MD |
| author_sort | Chern-En Chiang, MD, PhD |
| collection | DOAJ |
| description | Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF. |
| first_indexed | 2024-04-13T05:28:46Z |
| format | Article |
| id | doaj.art-4b1c142cc19643f3b3868b9813e7fac1 |
| institution | Directory Open Access Journal |
| issn | 1880-4276 |
| language | English |
| last_indexed | 2024-04-13T05:28:46Z |
| publishDate | 2017-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Arrhythmia |
| spelling | doaj.art-4b1c142cc19643f3b3868b9813e7fac12022-12-22T03:00:31ZengWileyJournal of Arrhythmia1880-42762017-08-0133434536710.1016/j.joa.2017.05.0042017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillationChern-En Chiang, MD, PhD0Ken Okumura, MD, PhD1Shu Zhang, MD2Tze-Fan Chao, MD, PhD3Chung-Wah Siu, MD4Toon Wei Lim, MD5Anil Saxena, MD6Yoshihide Takahashi, MD7Wee Siong Teo, MD8General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, TaiwanDivision of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, JapanState Key Laboratory of Cardiovascular Disease, Fuwai Hospital; National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People׳s Republic of ChinaDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, ChinaNational University Heart Centre, National University Hospital, SingaporeCardiac Pacing & Electrophysiology Center, Fortis Escorts Heart Institute, New Delhi, IndiaDepartment of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, JapanNational Heart Centre, SingaporeAtrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF-associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF-associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non-vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub-committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub-committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.http://www.sciencedirect.com/science/article/pii/S1880427617300984AnticoagulationAtrial fibrillationNon-vitamin K antagonist oral anticoagulantsVitamin K antagonistStroke |
| spellingShingle | Chern-En Chiang, MD, PhD Ken Okumura, MD, PhD Shu Zhang, MD Tze-Fan Chao, MD, PhD Chung-Wah Siu, MD Toon Wei Lim, MD Anil Saxena, MD Yoshihide Takahashi, MD Wee Siong Teo, MD 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation Journal of Arrhythmia Anticoagulation Atrial fibrillation Non-vitamin K antagonist oral anticoagulants Vitamin K antagonist Stroke |
| title | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| title_full | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| title_fullStr | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| title_full_unstemmed | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| title_short | 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation |
| title_sort | 2017 consensus of the asia pacific heart rhythm society on stroke prevention in atrial fibrillation |
| topic | Anticoagulation Atrial fibrillation Non-vitamin K antagonist oral anticoagulants Vitamin K antagonist Stroke |
| url | http://www.sciencedirect.com/science/article/pii/S1880427617300984 |
| work_keys_str_mv | AT chernenchiangmdphd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT kenokumuramdphd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT shuzhangmd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT tzefanchaomdphd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT chungwahsiumd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT toonweilimmd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT anilsaxenamd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT yoshihidetakahashimd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation AT weesiongteomd 2017consensusoftheasiapacificheartrhythmsocietyonstrokepreventioninatrialfibrillation |